Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review

Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review

<b>Objective:</b> To review the efficacy and safety of reduced dose compared to standard dose Enzalutamide treatment for patients with castration-resistant prostate cancer (CRPC). <b>Methods:</b> PubMed, Scopus, Web of Science, and Cochrane databases were searched for randomi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zineddine Belabaci, Lucas Mose, Omar El-Taji, Zina Otmani, Zein Alabdin Hannouneh, Issa Mohamad, Thomas Zilli, Osama Mohamad, Nadeem Pervez, Waleed Arafat, Ursula Vogl, Mohamed Shelan
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Pharmaceuticals
Subjects:	castration-resistant prostate cancer enzalutamide dose efficacy adverse events
Online Access:	https://www.mdpi.com/1424-8247/18/5/732
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short-term efficacy of enzalutamide in treatment of patients with abiraterone-resistant metastatic castration-resistant prostate cancer
by: MEI Jingchang, SU Xiaonan, YAO Yu, GUAN Fengju, ZHANG Guiming
Published: (2025-02-01)

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
by: Armen Aprikian, et al.
Published: (2025-02-01)

Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients
by: N. K. Mazina, et al.
Published: (2017-11-01)

SURVIVAL EFFECT OF PALLIATIVE RADIOTHERAPY IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER DEVELOPING OLIGO-PROGRESSION UNDER ANTIANDROGEN TREATMENT
by: Sabin Göktaş Aydın, et al.
Published: (2023-03-01)

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure metastatic castration-resistant prostate cancer
by: Zhiyu Zhang, et al.
Published: (2025-08-01)

Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
by: Saizo Fujmoto, et al.
Published: (2023-02-01)

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer
by: N. A. Avxentyev, et al.
Published: (2019-01-01)

Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer
by: Zhe Zhu, et al.
Published: (2024-11-01)

Integrated bioinformatics analysis reveals that OPRK1 inhibits ferroptosis and induces enzalutamide resistance in prostate cancer
by: Liangrong Zhang, et al.
Published: (2025-04-01)

Targeting TR4 nuclear receptor-mediated p21 downregulation to increase apoptosis for reverse of the Enzalutamide-resistance in prostate cancer
by: Xuedong Chen, et al.
Published: (2025-05-01)

ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
by: Jinpeng Cen, et al.
Published: (2025-06-01)

Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
by: Jinpeng Cen, et al.
Published: (2025-06-01)

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel
by: Hakan Taban, et al.
Published: (2025-06-01)

Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer
by: Fu-Hao Ji, et al.
Published: (2025-08-01)

Targeting the cancer cells and cancer‐associated fibroblasts with next‐generation FGFR inhibitors in prostate cancer co‐culture models
by: Syeda Afshan, et al.
Published: (2024-09-01)

Repurposing piroxicam enhances the antineoplastic effects of docetaxel and enzalutamide in prostate cancer cells using 2D and 3D in vitro culture models
by: Amani Yehya, et al.
Published: (2025-07-01)

Two restraining devices in connection to surgical castration with or without local anesthesia: effects on piglet stress
by: Ann-Helena Hokkanen, et al.
Published: (2025-04-01)

The Use of Lidocaine-Infused Castration Bands to Castrate Beef–Dairy Calves and Its Effect on Animal Welfare and Performance
by: Madeline R. Mancke, et al.
Published: (2025-02-01)

THERMAL CASTRATION AS A METHOD OF GAMETOPHYTIC SELECTION TO INCREASE ADAPTABILITY
by: A. N. Borovik, et al.
Published: (2018-05-01)

A Case Report of Self-Inflicted Surgical Castration
by: Koo Han Yoo, et al.
Published: (2023-12-01)

Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan
by: Takahiro Kimura, et al.
Published: (2025-02-01)

An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
by: Ruilin Zhuang, et al.
Published: (2025-04-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY
by: G. S. Krasnov, et al.
Published: (2016-02-01)

Impact of Burdizzo and Surgical Castration on Immune and Oxidative Stress Markers in Cattle
by: Thanyakorn Chalalai, et al.
Published: (2025-06-01)

Amphibian newts as experimental models for studying weight gain after castration
by: Mai Takehara, et al.
Published: (2024-02-01)

Role of exosomes in castration-resistant prostate cancer
by: Yuan Cao, et al.
Published: (2025-05-01)

Philosophical Foundation of Chemical Castration for Offenders of Sexual Violence Against Children
by: Henny Yuningsih, et al.
Published: (2020-01-01)

A novel lncRNA FLJ promotes castration resistance in prostate cancer through AR mediated autophagy
by: Yingying Wu, et al.
Published: (2025-03-01)

Screening and validation of key genes involved in castration-resistant prostate cancer based on transcriptomics sequencing
by: Guangquan Tong, et al.
Published: (2025-07-01)

FATTY ACID COMPOSITION OF LONGISSIMUS DORSI MUSCLE OF BLACK GOATS AND MERIZ KIDS AS INFLUENCED BY CASTRATION AND SLAUGHTER WEIGHT
by: Chinar Hassan, et al.
Published: (2023-03-01)

Ratio Legis of Chemical Castration to the Perpetrators of Sexual Violence against Children
by: Henny Yuningsih
Published: (2020-07-01)

Long-term ultrasonographic changes of the canine prostate gland after castration
by: Stefano Spada, et al.
Published: (2025-01-01)

Effect of castration and days on feed on body composition, glucose tolerance, and muscle gene expression in Nellore cattle
by: Luiz Henrique Pereira Silva, et al.
Published: (2025-08-01)

Treatment decision-making and treatment experiences in men with metastatic castration-resistant prostate cancer
by: Sandra Doveson, et al.
Published: (2025-03-01)

Dependence of piglet productivity on the method of their castration with dry feeding method
by: D. V. Zhdanov, et al.
Published: (2024-09-01)

Wnt5a augments intracellular free cholesterol levels and promotes castration resistance in prostate cancer
by: Yuqi Guo, et al.
Published: (2025-03-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

The effect of a non-steroidal anti-inflammatory drug on the locomotor activity of reindeer (Rangifer tarandus tarandus) on their natural pastures after clamp castration—a pilot study
by: Hanna Nurmi, et al.
Published: (2025-04-01)

A Super‐Enhancer‐Driven Transcriptional Regulatory Circuit Underlying Abiraterone Resistance in Castration‐Resistant Prostate Cancer
by: Liling Jiang, et al.
Published: (2025-08-01)